Mulpleta® (lusutrombopag) – New drug approval
July 31, 2018 - Shionogi announced the FDA approval of Mulpleta (lusutrombopag), for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure.
Download PDF
